Site Start Up EUCTR I

When our values align, there's no limit to what we can achieve.
 
At Parexel, we all share the same goal - to improve the world's health. From clinical trials to regulatory, consulting, and market access, every clinical development solution we provide is underpinned by something special - a deep conviction in what we do.

Each of us, no matter what we do at Parexel, contributes to the development of a therapy that ultimately will benefit a patient. We take our work personally, we do it with empathy and we're committed to making a difference.

Responsible for planning and submitting the simple EUCTR submissions i.e. Phase I initial submissions, Mono national initial submissions, substantial and non-substantial modification submission etc.

CORE JOB RESPONSIBILITIES: 

• Collaborate with Clinical Trial Management functional representatives to determine key study milestones and country allocation strategies. 

• Engage with Regulatory Affairs functional representatives to plan the part-II Clinical Trial Application (CTA) for EU countries. 

• Identify the list of Member State/countries participating in any one clinical trial and capture the information within the CTIS database. 

• Identify the Institutions and Primary Investigators for each Member State/Country where the clinical trial will be conducted and capture relevant contact information within the CTIS database. 

• Collect the documents that are deemed applicable at the Member State/country and/or site level for the purposes of Clinical Trial Application (CTA) submissions and upload them into the CTIS database. 

• Liase with Clinical Transparency regarding any redactions required for relevant documents identified for CTA submissions. 

• Monitor and report on the progress of Part II activities to ensure alignment with overall trial timelines and objectives. 

• Ensure part-II CTA comply with national regulatory requirements in each member state where the trial is conducted 

• Triage any questions that surface (Requests For Information) as a result of capturing and/or reporting on REGN clinical trial applications and work with relevant stakeholders to have RFI responses generated.  

• Collect required documents for IVDR (In Vitro Diagnostic Regulation) ethics submission and ensure all collected documents comply with the IVDR country requirements.  

• Ensure that all trial-related documents are archived in compliance with regulatory requirements and company policies. 

• Identify the key study level and Member State/country level milestones that represent Study Start, Study Completion, Enrollment Start, Enrollment Completion and any potential hold/restart/cancel dates that may apply to the study and capture the relevant dates within the CTIS database. 

• Maintain and manage the list of participating Member States/countries, Institutions and Primary Investigator over the life cycle of the study to ensure alignment and synchronization. 

Job Requirements: In addition to the core duties outlined, the following qualifications are required for the Site Start Up EUCTR Level I  

• Interpersonal & leadership skills 

• Ability to understand and implement the operational strategic direction and guidance for respective clinical studies 

• A data driven approach to planning, executing, and problem solving 

• Effective communication skills via verbal, written and presentation abilities 

• Proactive and self-disciplined, ability to meet deadlines, effective use of time, and prioritization 

• Ability to build productive study teams collaborations 

• Vendor management experience 

• Basic proficiency in trial management systems (CTMS, TMF) and MS applications including (but not limited to) Project, PowerPoint, Word, Excel 

• Experience in the clinical drug development process, including study start-up 

• Knowledge of ICH/GCP, EUCTR and IVDR regulatory guidelines 

• Basic project management skills, cross-functional team interaction and organizational skills 

• May require up to 25% travel 

• Bachelor’s degree and 1-2 years of relevant experience.